New Draft Guidance for Investigational New Drug Application and Bioavailability/Bioequivalence Studies
The FDA has released a new draft guidance for sponsors and sponsor investigators entitled “Safety Reporting Requirements and Safety Assessment for Investigational New Drug (IND)...
Read The Article